Atomwise: Abraham Heifets on how AI is redefining drug discovery

Brains Behind AI

On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise is on the fast-track to revolutionizing the healthcare industry. Tune in to hear Atomwise’s fascinating story of how they raised $123 million in funding last year alone, and how the company is using AI to develop pharmaceutical drugs.
https://www.atomwise.com/